NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar
NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. https://stockanalysis.com/stocks/nby/